As Sanofi and Regeneron await the FDA decision, a legal dispute between the partners over commercialisation details continues ...
The U.S. Food and Drug Administration has approved a new drug application for a tablet version of Evrysdi (risdiplam) for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback